Kelly A Meckling | OMICS International
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kelly A Meckling

 Kelly A Meckling
Department of Human Health and Nutritional Sciences
University of Guelph, Guelph, ON, Canada, N1G2W1.


Dr. Kelly A Meckling’s interest in mammalian biology began as a summer research student in the laboratory of Dr. Bob Church at the University of Calgary. She completed her PhD in the department of Medical Biophysics at University of T. She expanded this interest to show that fatty acids from fish oil and a number of phytochemicals and hormone active nutrients could alter both chemosensitivity of tumor cells to therapeutic agents, as well as modulate cell fate, particularly in blood cell development. Her major focus is on understanding the molecular mechanisms that control cell metabolism and to use this information to improve human health.


Research Interest

I am interested in the role of nutrition and diet in normal animal development and the processes that go awry in the development of chronic disease. I am specifically interested in the molecular mechanisms by which nutrients, phytochemicals and other components of food modulate cellular metabolism to affect cellular differentiation, cell proliferation and cell death. My core research program, supported by NSERC, is examining the signalling pathways involved in cellular responses to the hormone-active nutrient, calcitriol (1, 25 dihdyroxyvitamin D3). We are identifying signalling partners for a novel membrane vitamin D receptor (MARRS) and how these pathways interact with those of omega-3 fatty acids in normal blood and breast tissue development. These studies also have implications for the prevention and treatment of breast and blood cell cancers, since many of these pathways are dysfunctional or altered during the process of carcinogenesis.
In a secondary area of study, we are examining bioactive polyphenols (flavonoids, anthocyanins) found in highly coloured fruits and vegetables for activity as preventive or treatment agents for cardiovascular disease, diabetes and cancer. Many of the polyphenols we have studied (from red wine and osage orange) have potent antitumour activity and seem to spare normal tissues. We are examining the mechanisms by which these polyphenols achieve their selectivity and identifying their molecular targets.


Global Speakers in the subject

Global Experts in the subject